India Nippon Electricals Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 19, 2025, 9:24 pm

Competitors of India Nippon Electricals Ltd

All Competitor Stocks of India Nippon Electricals Ltd

Quarterly Result

Last Updated: August 20, 2025, 9:15 am

Below is a detailed analysis of the quarterly data for India Nippon Electricals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 225.00 Cr.. The value appears to be declining and may need further review. It has decreased from 234.00 Cr. (Mar 2025) to 225.00 Cr., marking a decrease of 9.00 Cr..
• For Expenses, as of Jun 2025, the value is 202.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 206.00 Cr. (Mar 2025) to 202.00 Cr., marking a decrease of 4.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 23.00 Cr.. The value appears to be declining and may need further review. It has decreased from 28.00 Cr. (Mar 2025) to 23.00 Cr., marking a decrease of 5.00 Cr..
• For OPM %, as of Jun 2025, the value is 10.00%. The value appears to be declining and may need further review. It has decreased from 12.00% (Mar 2025) to 10.00%, marking a decrease of 2.00%.
• For Other Income, as of Jun 2025, the value is 12.00 Cr.. The value appears strong and on an upward trend. It has increased from 9.00 Cr. (Mar 2025) to 12.00 Cr., marking an increase of 3.00 Cr..
• For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Depreciation, as of Jun 2025, the value is 4.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 6.00 Cr. (Mar 2025) to 4.00 Cr., marking a decrease of 2.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 30.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 30.00 Cr..
• For Tax %, as of Jun 2025, the value is 24.00%. The value appears to be increasing, which may not be favorable. It has increased from 10.00% (Mar 2025) to 24.00%, marking an increase of 14.00%.
• For Net Profit, as of Jun 2025, the value is 23.00 Cr.. The value appears to be declining and may need further review. It has decreased from 27.00 Cr. (Mar 2025) to 23.00 Cr., marking a decrease of 4.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 10.26. The value appears to be declining and may need further review. It has decreased from 11.94 (Mar 2025) to 10.26, marking a decrease of 1.68.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:09 am

Growth

Last Updated: September 5, 2025, 7:00 am

Balance Sheet

Last Updated: September 10, 2025, 1:49 pm

Below is a detailed analysis of the balance sheet data for India Nippon Electricals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 11.00 Cr..
• For Reserves, as of Mar 2025, the value is 700.00 Cr.. The value appears strong and on an upward trend. It has increased from 612.00 Cr. (Mar 2024) to 700.00 Cr., marking an increase of 88.00 Cr..
• For Borrowings, as of Mar 2025, the value is 2.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 3.00 Cr. (Mar 2024) to 2.00 Cr., marking a decrease of 1.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 226.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 211.00 Cr. (Mar 2024) to 226.00 Cr., marking an increase of 15.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 939.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 837.00 Cr. (Mar 2024) to 939.00 Cr., marking an increase of 102.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 154.00 Cr.. The value appears strong and on an upward trend. It has increased from 143.00 Cr. (Mar 2024) to 154.00 Cr., marking an increase of 11.00 Cr..
• For CWIP, as of Mar 2025, the value is 4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 13.00 Cr. (Mar 2024) to 4.00 Cr., marking a decrease of 9.00 Cr..
• For Investments, as of Mar 2025, the value is 472.00 Cr.. The value appears strong and on an upward trend. It has increased from 432.00 Cr. (Mar 2024) to 472.00 Cr., marking an increase of 40.00 Cr..
• For Other Assets, as of Mar 2025, the value is 308.00 Cr.. The value appears strong and on an upward trend. It has increased from 249.00 Cr. (Mar 2024) to 308.00 Cr., marking an increase of 59.00 Cr..
• For Total Assets, as of Mar 2025, the value is 939.00 Cr.. The value appears strong and on an upward trend. It has increased from 837.00 Cr. (Mar 2024) to 939.00 Cr., marking an increase of 102.00 Cr..

Notably, the Reserves (700.00 Cr.) exceed the Borrowings (2.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for India Nippon Electricals Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 36.37. This value is within the healthy range. It has increased from 26.21 (Mar 24) to 36.37, marking an increase of 10.16.
• For Diluted EPS (Rs.), as of Mar 25, the value is 36.37. This value is within the healthy range. It has increased from 26.21 (Mar 24) to 36.37, marking an increase of 10.16.
• For Cash EPS (Rs.), as of Mar 25, the value is 45.46. This value is within the healthy range. It has increased from 32.89 (Mar 24) to 45.46, marking an increase of 12.57.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 314.40. It has increased from 275.53 (Mar 24) to 314.40, marking an increase of 38.87.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 314.40. It has increased from 275.53 (Mar 24) to 314.40, marking an increase of 38.87.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 373.49. It has increased from 320.11 (Mar 24) to 373.49, marking an increase of 53.38.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 54.77. This value is within the healthy range. It has increased from 40.34 (Mar 24) to 54.77, marking an increase of 14.43.
• For PBIT / Share (Rs.), as of Mar 25, the value is 45.68. This value is within the healthy range. It has increased from 33.67 (Mar 24) to 45.68, marking an increase of 12.01.
• For PBT / Share (Rs.), as of Mar 25, the value is 45.50. This value is within the healthy range. It has increased from 33.50 (Mar 24) to 45.50, marking an increase of 12.00.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 36.37. This value is within the healthy range. It has increased from 26.22 (Mar 24) to 36.37, marking an increase of 10.15.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 36.37. This value is within the healthy range. It has increased from 26.22 (Mar 24) to 36.37, marking an increase of 10.15.
• For PBDIT Margin (%), as of Mar 25, the value is 14.66. This value is within the healthy range. It has increased from 12.60 (Mar 24) to 14.66, marking an increase of 2.06.
• For PBIT Margin (%), as of Mar 25, the value is 12.22. This value is within the healthy range. It has increased from 10.51 (Mar 24) to 12.22, marking an increase of 1.71.
• For PBT Margin (%), as of Mar 25, the value is 12.18. This value is within the healthy range. It has increased from 10.46 (Mar 24) to 12.18, marking an increase of 1.72.
• For Net Profit Margin (%), as of Mar 25, the value is 9.73. This value is within the healthy range. It has increased from 8.18 (Mar 24) to 9.73, marking an increase of 1.55.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 9.73. This value is within the healthy range. It has increased from 8.18 (Mar 24) to 9.73, marking an increase of 1.55.
• For Return on Networth / Equity (%), as of Mar 25, the value is 11.56. This value is below the healthy minimum of 15. It has increased from 9.51 (Mar 24) to 11.56, marking an increase of 2.05.
• For Return on Capital Employeed (%), as of Mar 25, the value is 13.67. This value is within the healthy range. It has increased from 11.42 (Mar 24) to 13.67, marking an increase of 2.25.
• For Return On Assets (%), as of Mar 25, the value is 8.76. This value is within the healthy range. It has increased from 7.08 (Mar 24) to 8.76, marking an increase of 1.68.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.95. It has increased from 0.93 (Mar 24) to 0.95, marking an increase of 0.02.
• For Current Ratio (X), as of Mar 25, the value is 2.38. This value is within the healthy range. It has decreased from 2.51 (Mar 24) to 2.38, marking a decrease of 0.13.
• For Quick Ratio (X), as of Mar 25, the value is 1.99. This value is within the healthy range. It has decreased from 2.11 (Mar 24) to 1.99, marking a decrease of 0.12.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 11.95. This value exceeds the healthy maximum of 8. It has increased from 11.56 (Mar 24) to 11.95, marking an increase of 0.39.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 34.37. This value is within the healthy range. It has decreased from 39.08 (Mar 24) to 34.37, marking a decrease of 4.71.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 27.49. This value is within the healthy range. It has decreased from 31.16 (Mar 24) to 27.49, marking a decrease of 3.67.
• For Earning Retention Ratio (%), as of Mar 25, the value is 65.63. This value is within the healthy range. It has increased from 60.92 (Mar 24) to 65.63, marking an increase of 4.71.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 72.51. This value exceeds the healthy maximum of 70. It has increased from 68.84 (Mar 24) to 72.51, marking an increase of 3.67.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 317.64. This value is within the healthy range. It has increased from 234.00 (Mar 24) to 317.64, marking an increase of 83.64.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 211.97. This value is within the healthy range. It has increased from 153.05 (Mar 24) to 211.97, marking an increase of 58.92.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,332.58. It has decreased from 1,516.90 (Mar 24) to 1,332.58, marking a decrease of 184.32.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.58. This value is within the healthy range. It has decreased from 2.09 (Mar 24) to 1.58, marking a decrease of 0.51.
• For EV / EBITDA (X), as of Mar 25, the value is 10.76. This value is within the healthy range. It has decreased from 16.62 (Mar 24) to 10.76, marking a decrease of 5.86.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.60. This value is within the healthy range. It has decreased from 2.12 (Mar 24) to 1.60, marking a decrease of 0.52.
• For Retention Ratios (%), as of Mar 25, the value is 65.62. This value is within the healthy range. It has increased from 60.91 (Mar 24) to 65.62, marking an increase of 4.71.
• For Price / BV (X), as of Mar 25, the value is 1.91. This value is within the healthy range. It has decreased from 2.46 (Mar 24) to 1.91, marking a decrease of 0.55.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.60. This value is within the healthy range. It has decreased from 2.12 (Mar 24) to 1.60, marking a decrease of 0.52.
• For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.06, marking an increase of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness